EWM
GTF

Edge Wealth Management’s CYTOMEDIX INC COM NEW GTF Stock Holding History

Edge Wealth Management’s Portfolio GTF Stock Details GTF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-27,000
Closed -$11K – 461
2014
Q3 		$11K Hold
27,000
– – ﹤0.01% 307
2014
Q2 		$11K Hold
27,000
– – ﹤0.01% 287
2014
Q1 		$14K Hold
27,000
– – 0.01% 268
2013
Q4 		$13K Hold
27,000
– – 0.01% 255
2013
Q3 		$11K Hold
27,000
– – 0.01% 237
2013
Q2 		$12K Buy
+27,000
New +$12K 0.01% 224

Edge Wealth Management's GTF Position: Q4 2014 in Review

Edge Wealth Management sold out of CYTOMEDIX INC COM NEW (GTF) in Q4 2014, closing a stake of 27,000 shares — an estimated $11K sold.

Edge Wealth Management first reported a position in GTF in Q2 2013 and held it in 6 quarters. The position peaked at $14K in Q1 2014. 0 funds tracked by Wall St. Rank hold GTF as of Q4 2014.

  • Edge Wealth Management reported no remaining CYTOMEDIX INC COM NEW position as of Q4 2014 after selling out during the quarter.
  • Edge Wealth Management sold 27,000 CYTOMEDIX INC COM NEW shares in Q4 2014, an estimated $11K.
  • Edge Wealth Management first reported a position in CYTOMEDIX INC COM NEW in Q2 2013 and held it in 6 quarters.
  • Edge Wealth Management's CYTOMEDIX INC COM NEW position peaked at $14K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held CYTOMEDIX INC COM NEW as of Q4 2014.

Based on Edge Wealth Management's 13F filing for Q4 2014, filed 12 Jan 2015.